metronic
You are here :

2012 l Cardiostim EHRA


Press release
For immediate release
CANCELBR
Contact:
contact@cr-communication.fr
Phone: +33 (0)1 49 74 42 01


Europe's leading congresses in cardiac electrophysiology agree to consolidate their events and develop a common scientific programme each year


Cardiostim and EHRA-Europace, Europe's leading congresses in "electrophysiology" and the treatment of heart rhythm disorders (such as atrial fibrillation) have formed a strategic alliance to ensure the development from year to year of a homogeneous congress programme devised under the direction of a common scientific committee.

Cardiostim and the EHRA (European Heart Rhythm Association) have had an agreement since 2006 whereby each organisation held their respective congresses in alternating years - Cardiostim in "even" years, and Europace in "odd". That arrangement will continue under the new agreement, but now with further scope for consistency, integration and homogeneity. Both organisations share a wish to avoid fragmentation and create a common vision and objective - to promote the field of electrophysiology in terms of training and accreditation, research, the exchange of clinical skills and co-operation with allied professionals and manufacturers.

Under today's agreement, both congresses will retain their independence in terms of brand, ownership and finance, but will join forces in the planning and preparation of scientific content. The agreement, therefore, which was signed by representatives of Cardiostim and EHRA-Europace on 26 June 2011, aims to reinforce the quality of each congress and provide a scientific continuum from one event to the next. Currently, each congress attracts almost 6000 participants.

The agreement between the two organisations is for six years, from 2012 to 2017 inclusive; years 2012 and 2013 are seen as transition years in which Cardiostim and EHRA-Europace will retain their respective congress rules and structures. However, from 2014 a single common scientific committee, composed of and chaired by members of each organisation, will develop the scientific programme and the two congresses will aggregate their names.

Each programme will be built around four main themes: electrophysiology and catheter ablation (one important approach to the treatment of cardiac arrhythmias), devices for the management of heart rhythm and heart failure, non-invasive approaches to rhythm disturbances, and basic science. Abstracts selected for inclusion will be published in the Europace-EHRA journal.

Commenting on the agreement, Professor Panos Vardas, President of the European Heart Rhythm Association, said: "The EHRA is the indisputable European leader in the management of cardiac arrhythmias and we have entered this agreement with Cardiostim in the belief that together we can create a highly successful congress driven by a common programme committee. We believe that this strategic decision - which took two years of discussion to reach - will be welcomed by the majority of European arrhythmologists."

Dr Philippe Ritter, Chairman of Cardiostim, said: "This agreement is an historic event for the European electrophysiology community. Highly supported by the industry, this strategic alliance is the continuation of a rapprochement which started in 2006. Respectful of both organisations, it should now allow us to jointly accelerate the development of our congresses, as international congresses open to doctors and scientists from all over the world."




Notes for editors



* Cardiostim is an international congress created 33 years ago and dedicated to cardiac electrophysiology and cardiac techniques. It is organised and owned by Reed Expositions France, the French branch of the world's leading trade show and congress organiser Reed Exhibitions, itself a subsidiary of Reed Elsevier. Cardiostim is held every even year in Nice, France, and the latest event in 2010 attracted 5749 participants.

* The European Heart Rhythm Association, the leading organisation in the field of arrhythmias and electrophysiology in Europe, is a registered association of the European Society of Cardiology (ESC). Its congress, Europace-EHRA takes place every odd year at various venues throughout Europe and the latest event has attracted over 5500 participants.

* The European Society of Cardiology (ESC) represents more than 68,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.